These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 22480789)

  • 1. Measurement of aminoterminal propeptide of type I procollagen (PINP) in serum.
    Koivula MK; Risteli L; Risteli J
    Clin Biochem; 2012 Aug; 45(12):920-7. PubMed ID: 22480789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of total and intact aminoterminal propeptide of type I procollagen assays in patients with breast cancer with or without bone metastases.
    Marin L; Koivula MK; Jukkola-Vuorinen A; Leino A; Risteli J
    Ann Clin Biochem; 2011 Sep; 48(Pt 5):447-51. PubMed ID: 21733929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Difference between total and intact assays for N-terminal propeptide of type I procollagen reflects degradation of pN-collagen rather than denaturation of intact propeptide.
    Koivula MK; Ruotsalainen V; Björkman M; Nurmenniemi S; Ikäheimo R; Savolainen K; Sorva A; Risteli J
    Ann Clin Biochem; 2010 Jan; 47(Pt 1):67-71. PubMed ID: 19940208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term changes in serum PINP predict long-term changes in trabecular bone in the rat ovariectomy model.
    Rissanen JP; Suominen MI; Peng Z; Morko J; Rasi S; Risteli J; Halleen JM
    Calcif Tissue Int; 2008 Feb; 82(2):155-61. PubMed ID: 18219436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bone and bone related biochemical examinations. Bone and collagen related metabolites. Measurement of PICP and PINP in the evaluation of pharmaceutical treatment efficacy for osteoporosis].
    Nakatsuka K; Nishizawa Y; Miura M
    Clin Calcium; 2006 Jun; 16(6):977-85. PubMed ID: 16751694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum concentrations of type I collagen carboxyterminal telopeptide (ICTP) and type I procollagen carboxy-and aminoterminal propeptides (PICP, PINP) as markers of metastatic bone disease in breast cancer.
    Tähtelä R; Thölix E
    Anticancer Res; 1996; 16(4B):2289-93. PubMed ID: 8694558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term biochemical response after bisphosphonate therapy in Paget's disease of bone. Proposed intervals for monitoring treatment.
    Alvarez L; Peris P; Guañabens N; Vidal S; Quintó L; Monegal A; Pons F; Ballesta AM; Muñoz-Gómez J
    Rheumatology (Oxford); 2004 Jul; 43(7):869-74. PubMed ID: 15054158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The amino-terminal propeptide (PINP) of type I collagen is a clinically valid indicator of bone turnover and extent of metastatic spread in osseous metastatic breast cancer.
    Pollmann D; Siepmann S; Geppert R; Wernecke KD; Possinger K; Lüftner D
    Anticancer Res; 2007; 27(4A):1853-62. PubMed ID: 17649784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicenter study to evaluate harmonization of assays for N-terminal propeptide of type I procollagen (PINP): a report from the IFCC-IOF Joint Committee for Bone Metabolism.
    Cavalier E; Eastell R; Rye Jørgensen N; Makris K; Tournis S; Vasikaran S; Kanis JA; Cooper C; Pottel H; Morris HA;
    Clin Chem Lab Med; 2019 Sep; 57(10):1546-1555. PubMed ID: 31085740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a highly sensitive, high-throughput, mass spectrometry-based assay for rat procollagen type-I N-terminal propeptide (PINP) to measure bone formation activity.
    Han B; Copeland M; Geiser AG; Hale LV; Harvey A; Ma YL; Powers CS; Sato M; You J; Hale JE
    J Proteome Res; 2007 Nov; 6(11):4218-29. PubMed ID: 17924680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discriminative value of biochemical markers of bone turnover in assessing the activity of Paget's disease.
    Alvarez L; Guañabens N; Peris P; Monegal A; Bedini JL; Deulofeu R; Martinez de Osaba MJ; Muñoz-Gomez J; Rivera-Fillat F; Ballesta AM
    J Bone Miner Res; 1995 Mar; 10(3):458-65. PubMed ID: 7785468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levels of biochemical bone marker procollagen type I N-propeptide (PINP) in Thai women aged 40-70 years.
    Boonyanurak P; Wilawan K
    J Med Assoc Thai; 2009 Jul; 92(7):873-7. PubMed ID: 19626803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical usefulness of cross-linked N-telopeptide of type I collagen (NTx) as a bone metastatic marker in patients with prostate cancer--comparison with serum PICP, PINP and ICTP].
    Kobayashi Y; Ochi M; Tokue A
    Hinyokika Kiyo; 2000 Dec; 46(12):869-72. PubMed ID: 11211802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type I collagen metabolites as tumor markers in patients with lung carcinoma.
    Kobayashi T; Gabazza EC; Taguchi O; Risteli J; Risteli L; Kobayashi H; Yasui H; Yuda H; Sakai T; Kaneda M; Adachi Y
    Cancer; 1999 May; 85(9):1951-7. PubMed ID: 10223235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of circulating type I procollagen propeptides in patients with Paget's disease of bone.
    Bonnin MR; Moragues C; Nolla JM; Lirón FJ; Roig-Escofet D; Navarro MA
    Clin Chem Lab Med; 1998 Jan; 36(1):53-5. PubMed ID: 9594087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of an algorithm for using PINP to monitor treatment of patients with teriparatide.
    Eastell R; Krege JH; Chen P; Glass EV; Reginster JY
    Curr Med Res Opin; 2006 Jan; 22(1):61-6. PubMed ID: 16393431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of age-related chronic immobility on markers of bone turnover.
    Chen JS; Cameron ID; Cumming RG; Lord SR; March LM; Sambrook PN; Simpson JM; Seibel MJ
    J Bone Miner Res; 2006 Feb; 21(2):324-31. PubMed ID: 16418789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Serum PINP(N-terminal propeptide of type I procollagen)].
    Ueda M; Inaba M
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():373-7. PubMed ID: 15035155
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of three serum assays for bone collagen formation during postmenopausal estrogen-progestin therapy.
    Suvanto-Luukkonen E; Risteli L; Sundström H; Penttinen J; Kauppila A; Risteli J
    Clin Chim Acta; 1997 Oct; 266(2):105-16. PubMed ID: 9437539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of biochemical markers of bone turnover in assessing response to the treatment of Paget's disease.
    Alvarez L; Guañabens N; Peris P; Vidal S; Ros I; Monegal A; Bedini JL; Deulofeu R; Pons F; Muñoz-Gomez J; Ballesta AM
    Bone; 2001 Nov; 29(5):447-52. PubMed ID: 11704497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.